Health Care · Services-Health Services

OMDA Omada Health, Inc. SEC Filings & Insider Trading Activity 2026

company
CIK 1611115116 filings
Russell 2000

OMDA at a glance

Omada Health, Inc. (OMDA, SEC CIK 1611115) filed its latest 10-K annual report on March 6, 2026, a 10-Q quarterly report on November 6, 2026, an 8-K current report on November 5, 2026 and Form 4 insider filings as recently as November 6, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), Omada Health, Inc. (OMDA) reported revenue of $260.2 million (up 53.2% from FY2024) and a net loss of $12.8 million. Diluted EPS was -$0.35.
  • As of September 30, 2026, 24 institutional investment managers tracked by SignalX reported holding Omada Health, Inc. (OMDA) shares worth $449.1 million in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by Duffy Sean P. on November 4, 2026 of 12,944 shares at $19.22 per share.
  • In the last 90 days, OMDA insiders reported 0 open-market purchases ($0) and 15 open-market sales ($1.7M) on Form 4, a net sale of $1.7M.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$260.2M
+53.2% vs prior year
Insiders · 90 days
0 buys · 15 sells
Net −$1.7M
13F holders
24 funds
$449.1M · +1 vs prior quarter
Latest 8-K
Nov 5, 2026
Item 2.02

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • Newly added AI risk: December 2025 Executive Order and March 2026 framework create uncertainty over state-law preemption and compliance costs
  • Regulatory risk: evolving AI requirements may force platform redesign, increase expenses, and trigger claims or enforcement
  • Competitive risk: AI-native healthcare offerings may deliver care at lower operating cost and reduce demand for Omada programs
  • Customer concentration: top five health plan and PBM partners generated 78% of nine-month 2026 revenue, including Cigna affiliates
  • Financial risk: accumulated deficit reached $447.9 million as of September 30, 2026 despite nine-month net income of $8.9 million

Management Discussion & Analysis

  • Q3 revenue $91.3M, up 34% YoY from $68.0M, driven by services revenue of $85.1M, up 35%
  • Gross margin increased 10 percentage points YoY, with gross profit $69.3M versus $45.1M
  • Services best-performing line, up $22.2M YoY; hardware revenue $6.2M, up 22% to $5.1M
  • Nine-month operating cash flow $7.3M versus $(3.1)M, with $4.9M invested in software and equipment
  • Cash and equivalents $243.2M; tariff-related device costs and rising GLP-1 affordability pressures remain headwinds

AI summary of the OMDA 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 5, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Omada Health announced financial results for the three months ended September 30, 2026
  • Full revenue, profitability, and guidance details are in Exhibit 99.1, the accompanying earnings release

Item EX-99.1: Item EX-99.1

  • Q3 revenue $91.3M, up 34% year over year, with services revenue driving growth at $85.1M
  • GAAP gross margin expanded to 76% from 66%, while net income reached $6.6M versus a $3.2M loss
Filed Aug 6, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q2 2026 results announced for the three months ended June 30, 2026
  • Investor-relevant financial figures and management commentary are contained in Exhibit 99.1

Item EX-99.1: Item EX-99.1

  • Q2 revenue $87.8M, up 43% year over year, with total members up 45%, signaling strong demand and enrollment momentum
  • Gross margin reached 73% from 66%, while adjusted EBITDA rose to $10.8M from a $0.2M loss, marking meaningful operating leverage

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • CEO transition effective January 1, 2027: President Wei-Li Shao succeeds Sean Duffy
  • Duffy becomes Executive Chairman, preserving founder-level leadership and strategic continuity
Filed Jun 16, 2026Full analysis →

Item 5.07: Submission of Matters to a Vote of Security Holders

  • Sean Duffy and Trevor Fetter reelected as Class I directors through the 2029 annual meeting
  • Duffy received 18,540,089 votes for and Fetter 18,538,042, with 13,920,625 broker non-votes each

AI summaries of OMDA 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for OMDA

Don't miss the next OMDA filing

  • Alerts as it files. A push when OMDA files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut OMDA, by share count.
  • Ask anything. An AI agent that reads every OMDA filing and answers with sources.

OMDA alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Duffy Sean P.SellNov 4, 2026$19.22
Duffy Sean P.MNov 4, 2026-
Duffy Sean P.MNov 4, 2026$5.82
HILLEMAN JERYL LAOct 5, 2026-
FETTER TREVORAOct 5, 2026-
Klapstein Julie DAOct 5, 2026-
ROOT JONATHAN DAOct 5, 2026-
Duffy Sean P.MOct 1, 2026$8.28

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$169.8M$260.2M
Gross Profit-$102.9M$170.9M
Operating Income--$43.7M-$12.0M
Net Income--$47.1M-$12.8M
Gross Margin-60.6%65.7%
Op. Margin--25.7%-4.6%
Net Margin--27.8%-4.9%
Balance Sheet
Total Assets-$150.9M$305.4M
Equity-$350.1M-$384.4M$229.7M
ROE-12.3%-5.6%
Per Share
EPS-$-6.11$-0.35
Cash Flow
Operating CF--$34.2M$18.3M
CapEx$416K$596K$1.3M

Source: XBRL data in Omada Health, Inc. (OMDA)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate OMDA share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
OMDA shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202624$449.1M
Q2 202623$364.6M
Q1 202622$162.3M
Q4 202518$184.3M
Q3 202516$157.0M
Q2 202512$130.1M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 115 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

OMDA filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
10-QNov 6, 2026Analysis
4Nov 6, 2026--
8-KNov 5, 2026Analysis-
4Oct 7, 2026--
4Oct 7, 2026--
4Oct 7, 2026--
4Oct 7, 2026--
4Oct 5, 2026--
4Sep 14, 2026--
4Sep 14, 2026--
4Sep 14, 2026--
4Sep 11, 2026--
4Sep 9, 2026--
4Sep 9, 2026--
4Sep 9, 2026--
4Sep 4, 2026--
4Sep 3, 2026--
4Sep 3, 2026--
4Sep 3, 2026--
4Sep 3, 2026--
4Aug 31, 2026--
SC 13GAug 14, 2026-
4Aug 12, 2026--
4Aug 12, 2026--
4Aug 12, 2026--

Related Health Care companies

All Health Care →

OMDA SEC filings: frequently asked questions

Are OMDA insiders buying or selling?

In the last 90 days, Omada Health, Inc. (OMDA) officers, directors and 10% owners reported no open-market purchases and 15 open-market sales worth $1.7 million by 4 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold OMDA stock?

As of September 30, 2026, the largest Omada Health, Inc. (OMDA) holders among the 13F filers tracked by SignalX were BlackRock ($78.3 million), Morgan Stanley ($67.4 million), D.E. Shaw & Co ($61.8 million), Vanguard Capital Management LLC ($51.1 million), Millennium Management ($29.3 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was OMDA's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), Omada Health, Inc. (OMDA) reported revenue of $260.2 million (up 53.2% from FY2024) and a net loss of $12.8 million. Diluted EPS was -$0.35. The figures come from the XBRL data in the 10-K.

What did OMDA report in its latest 8-K?

Omada Health, Inc. (OMDA) filed an 8-K on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Omada Health announced financial results for the three months ended September 30, 2026.

What are the latest OMDA SEC filings?

Omada Health, Inc. (OMDA) filed its latest 10-K annual report on March 6, 2026, a 10-Q quarterly report on November 6, 2026, an 8-K current report on November 5, 2026 and a Form 4 insider filing on November 6, 2026.

What is OMDA's SEC CIK number?

Omada Health, Inc. (OMDA)'s SEC Central Index Key (CIK) is 1611115. EDGAR lists every OMDA filing under that number.

Ask anything about OMDA

The research agent reads OMDA's filings, financials, insider trades and 13F holders, then answers with sources.